Combined therapy with inhaled nitric oxide and intravenous epoprostenol (prostacyclin) for critical pulmonary perfusion after the Fontan procedure

Journal of Thoracic and Cardiovascular Surgery

Volumn 125, Issue 2, 2003, Pages 437-439

  Miyaji, Kagami ^a   Nagata, Nobuhiro ^a   Miyamoto, Takashi ^a   Kitahori, Kazuo ^a  

^a KANAGAWA CHILDREN'S MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; PROSTACYCLIN;

ARTERIAL OXYGEN SATURATION; ARTERIAL PRESSURE; ARTICLE; CASE REPORT; CENTRAL VENOUS PRESSURE; DRUG DOSE REDUCTION; DRUG POTENTIATION; DRUG WITHDRAWAL; FEMALE; FONTAN PROCEDURE; HEART LEFT ATRIUM PRESSURE; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART SINGLE VENTRICLE; HEMODYNAMIC MONITORING; HUMAN; LUNG ARTERY PRESSURE; LUNG ATRESIA; LUNG PERFUSION; LUNG VASCULAR RESISTANCE; LUNG VASOCONSTRICTION; MALE; OUTCOMES RESEARCH; OXYGEN TENSION; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VALVE STENOSIS; REBOUND; SIDE EFFECT;

EID: 0037326862     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2003.199     Document Type: Article

References (4)

1. Miller OI, Clermajer DS, Deanfield JE, Macrae DJ. Very-low-dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg. 1994;108:487-94.
2. Atz AM, Adatia I, Wessel DL. Rebound pulmonary hypertension after inhalation of nitric oxide. Ann Thorac Surg. 1996;62:1759-64.
3. Hermon M, Golej J, Burda G, Marx M, Trittenwein G, Pollak A. Intravenous prostacyclin mitigates inhaled nitric oxide rebound effect: a case control study. Artif Organs. 1999;23:975-8.
4. Goldman AP, Delius RE, Deanfield JE, Macrae DJ. Nitric oxide is superior to prostacyclin for pulmonary hypertension after cardiac operation. Ann Thorac Surg. 1995;60:300-6.